Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
Deborah Elstein,
Nadia Belmatoug,
Patrick Deegan,
Özlem Göker-Alpan,
Derralynn A Hughes,
Ida Vanessa D Schwartz,
Neal Weinreb,
Nicola Bonner,
Charlotte Panter,
Donna Fountain,
Andrew Lenny,
Louise Longworth,
Rachael Miller,
Koonal Shah,
Jörn Schenk,
Rohini Sen,
Ari Zimran
Feb 09, 2022
BACKGROUND: Disease-specific patient-reported outcome measures (PROMs) are fundamental to understanding the impact on, and expectations of, patients with genetic disorders, and can facilitate constructive and educated...